RESUMO
BACKGROUND: Recent emphasis on bundled payments and outcomes tracking has increased the focus on preoperative optimization in patients undergoing elective lower extremity arthroplasty. Since patients with obstructive sleep apnea (OSA) have an increased risk of adverse perioperative pulmonary events, screening for undiagnosed OSA is sometimes included as part of preoperative risk assessment. However, there are limited data regarding quantification of OSA risk in lower extremity arthroplasty patients, and little is known about the utility of quantitative OSA screening and the risk of pulmonary complications in hip and knee arthroplasty patients who receive intrathecal morphine anesthetic. METHODS: A retrospective review of 990 patients at a tertiary care, urban academic medical center who underwent lower extremity arthroplasty with a multimodal pain regimen including intrathecal morphine anesthesia, comparing the rate of pulmonary complications and length of stay between patients previously diagnosed with OSA and those identified as low, moderate, and high risk of undiagnosed OSA established by screening with the STOP-BANG questionnaire in the preoperative setting. RESULTS: Using logistic regression and adjusting for age, gender, and body mass index, the results suggested the rate of complications was not different across the sleep apnea risk groups (P = .4024). In addition, linear regression suggested length of stay did not differ significantly by sleep apnea risk group (P = .2823). CONCLUSION: In patients receiving intrathecal morphine as part of a multimodal pain regimen undergoing hip or knee arthroplasty, neither risk of adverse pulmonary events nor length of stay appeared to correlate with preoperative risk of undiagnosed OSA.
Assuntos
Analgésicos Opioides/administração & dosagem , Pneumopatias/etiologia , Morfina/administração & dosagem , Dor Pós-Operatória/prevenção & controle , Apneia Obstrutiva do Sono/complicações , Idoso , Anestesia , Anestésicos , Artroplastia de Quadril/efeitos adversos , Artroplastia do Joelho/efeitos adversos , Índice de Massa Corporal , Procedimentos Cirúrgicos Eletivos , Feminino , Humanos , Injeções Espinhais , Tempo de Internação , Masculino , Pessoa de Meia-Idade , Dor Pós-Operatória/etiologia , Estudos Retrospectivos , Fatores de Risco , Inquéritos e QuestionáriosAssuntos
Traumatismos da Mão/tratamento farmacológico , Ivermectina/uso terapêutico , Permetrina/uso terapêutico , Escabiose/diagnóstico , Escabiose/terapia , Dermatopatias/tratamento farmacológico , Administração Oral , Administração Tópica , Feminino , Traumatismos da Mão/diagnóstico , Traumatismos da Mão/parasitologia , Humanos , Ivermectina/administração & dosagem , Pessoa de Meia-Idade , Permetrina/administração & dosagem , Dermatopatias/diagnóstico , Dermatopatias/parasitologia , Resultado do TratamentoRESUMO
Extramammary Paget's disease (EMPD) is a rare cutaneous malignancy. The disease typically affects older individuals aged 60-80 years and is seen most frequently in postmenopausal Caucasian women and Asian men. EMPD exhibits a predilection for the genital and perianal regions and may be associated with an underlying carcinoma in adjacent organs. EMPD presents a challenge in both diagnosis and management. Often treated empirically as various dermatitides, the correct diagnosis is frequently delayed by many years. Following diagnosis, an extensive search for an associated malignancy should be initiated. If invasive disease is present on biopsy, a sentinel lymph node biopsy may guide further treatment. Mohs micrographic surgery appears to be superior to wide local excision when considering tissue sparing ability and disease recurrence. Nonsurgical interventions have also been investigated with varied results. Regardless of treatment method, long-term follow-up is recommended to monitor for local disease recurrence, development of internal malignancy, regional lymphadenopathy, or distant metastasis.